Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting
Report formulated by the Board of Directors under item Three of the Agenda - Only available in Spanish
Report formulated by the Board of Directors under item Four of the Agenda - Only available in Spanish
Identity, curriculum and category of the member of the Board of Directors proposed to the General Shareholders' Meeting under item Five of the Agenda - Only available in Spanish
Report of the Appointments and Compensation and Sustainability Committee justifying the proposal of the Board of Directors of the Company for the appointment of a non-independent Director under item Five of the Agenda - Only available in Spanish
Report formulated by the Board of Directors in relation to the proposal for the appointment of a non-independent Director under item Five of the Agenda - Only available in Spanish
Report formulated by the Board of Directors under item Six of the Agenda - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2020
Annual Report on Directors' Compensation for fiscal year 2020
Report of the Appointments and Compensation and Sustainability Committee on the proposed amendment to Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022 - Only available in Spanish
The Audit Committee's Report on independence of the external auditor - Only available in Spanish
2020 Operating Report by Audit Committeenly available in Spanish - Only available in Spanish
2020 Operating Report by the Appointments and Compensation and Sustainability Committee - Only available in Spanish
The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last Shareholders’ General Meeting - Only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish
Right to information - Only available in Spanish
Link Right to Information - Only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum of Pharma Mar - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
Quorum, agreements and Votes - Only available in Spanish
Report formulated by the Board of Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors under item Four of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2019
Annual Report on Directors' Compensation for fiscal year 2019
Report of the Appointments and Compensation Committee on the proposed Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022 - only available in Spanish
Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2019 Operating Report by Audit Committee - only available in Spanish
2019 Operating Report by the Appointments and Compensation Committee. - only available in Spanish
The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last Shareholders’ General Meeting - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Valid requests for information, clarifications or questions made by shareholders in the exercise of their right to information and the answers provided by the directors, if any - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
Quorum, agreements and Votes - Only available in Spanish
Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish
Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish
Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2018
Annual Report on Directors' Compensation for fiscal year 2018
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2018 Operating Report by Audit Committee - only available in Spanish
2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish
The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
Quorum, agreements and Votes - Only available in Spanish
Agreements - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2017
Annual Report on Directors’ Compensation for fiscal year 2017
Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021
The Audit Committee’s Report on independence of the external auditor - Only available in Spanish
2017 Operating Report by Audit Committee - Only available in Spanish
2017 Operating Report by the Appointments and Compensation Committee - Only available in Spanish
2017 corporate social responsibility report for the Pharma Mar Group
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish
Quorum, agreements and Votes - Only available in Spanish
Agreements - Only available in Spanish
Directors’ report on Agenda Item Three - Only available in Spanish
Directors’ report on Agenda Item Four - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2016
Annual Report on Directors’ Compensation for fiscal year 2016
The Audit Committee’s Report on independence of the external auditor - Only available in Spanish
2016 Operating Report by Audit Committee - Only available in Spanish
2016 corporate social responsibility report for the Pharma Mar Group
Quorum, agreements and Votes.
Only available in Spanish
Agreements.
Only available in Spanish
Annual Corporate Governance Report for fiscal year 2015.
Annual Report on Directors’ Compensation for fiscal year 2015.
Compensation Policy for 2016-2018 for the Directors of Pharma Mar.
The Audit Committee’s Report on independence of the external auditor (only available in Spanish).
2015 Corporate Social Responsibility report for the Pharma Mar Group.
Quorum, agreements and Votes - Only available in Spanish
Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish
Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish
Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2018
Annual Report on Directors' Compensation for fiscal year 2018
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2018 Operating Report by Audit Committee - only available in Spanish
2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish
The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
- 2021
-
Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting
Report formulated by the Board of Directors under item Three of the Agenda - Only available in Spanish
Report formulated by the Board of Directors under item Four of the Agenda - Only available in Spanish
Identity, curriculum and category of the member of the Board of Directors proposed to the General Shareholders' Meeting under item Five of the Agenda - Only available in Spanish
Report of the Appointments and Compensation and Sustainability Committee justifying the proposal of the Board of Directors of the Company for the appointment of a non-independent Director under item Five of the Agenda - Only available in Spanish
Report formulated by the Board of Directors in relation to the proposal for the appointment of a non-independent Director under item Five of the Agenda - Only available in Spanish
Report formulated by the Board of Directors under item Six of the Agenda - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2020
Annual Report on Directors' Compensation for fiscal year 2020
Report of the Appointments and Compensation and Sustainability Committee on the proposed amendment to Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022 - Only available in Spanish
The Audit Committee's Report on independence of the external auditor - Only available in Spanish
2020 Operating Report by Audit Committeenly available in Spanish - Only available in Spanish
2020 Operating Report by the Appointments and Compensation and Sustainability Committee - Only available in Spanish
The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last Shareholders’ General Meeting - Only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish
Right to information - Only available in Spanish
Link Right to Information - Only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum of Pharma Mar - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
- 2020
-
Quorum, agreements and Votes - Only available in Spanish
Report formulated by the Board of Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors under item Four of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2019
Annual Report on Directors' Compensation for fiscal year 2019
Report of the Appointments and Compensation Committee on the proposed Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022 - only available in Spanish
Pharma Mar, S.A.'s Directors' Compensation Policy for 2020-2022
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2019 Operating Report by Audit Committee - only available in Spanish
2019 Operating Report by the Appointments and Compensation Committee. - only available in Spanish
The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last Shareholders’ General Meeting - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Valid requests for information, clarifications or questions made by shareholders in the exercise of their right to information and the answers provided by the directors, if any - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
- 2019
-
Quorum, agreements and Votes - Only available in Spanish
Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish
Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish
Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2018
Annual Report on Directors' Compensation for fiscal year 2018
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2018 Operating Report by Audit Committee - only available in Spanish
2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish
The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish
- 2018
-
Quorum, agreements and Votes - Only available in Spanish
Agreements - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2017
Annual Report on Directors’ Compensation for fiscal year 2017
Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021
The Audit Committee’s Report on independence of the external auditor - Only available in Spanish
2017 Operating Report by Audit Committee - Only available in Spanish
2017 Operating Report by the Appointments and Compensation Committee - Only available in Spanish
2017 corporate social responsibility report for the Pharma Mar Group
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish
- 2017
-
Quorum, agreements and Votes - Only available in Spanish
Agreements - Only available in Spanish
Directors’ report on Agenda Item Three - Only available in Spanish
Directors’ report on Agenda Item Four - Only available in Spanish
Annual Corporate Governance Report for fiscal year 2016
Annual Report on Directors’ Compensation for fiscal year 2016
The Audit Committee’s Report on independence of the external auditor - Only available in Spanish
2016 Operating Report by Audit Committee - Only available in Spanish
2016 corporate social responsibility report for the Pharma Mar Group
- 2016
-
Quorum, agreements and Votes.
Only available in SpanishAgreements.
Only available in SpanishAnnual Corporate Governance Report for fiscal year 2015.
Annual Report on Directors’ Compensation for fiscal year 2015.
Compensation Policy for 2016-2018 for the Directors of Pharma Mar.
The Audit Committee’s Report on independence of the external auditor (only available in Spanish).
2015 Corporate Social Responsibility report for the Pharma Mar Group.
- 2015 (Zeltia)
-
Quorum, agreements and Votes - Only available in Spanish
Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish
Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish
Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish
Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish
Annual Corporate Governance Report for fiscal year 2018
Annual Report on Directors' Compensation for fiscal year 2018
The Audit Committee's Report on independence of the external auditor - only available in Spanish
2018 Operating Report by Audit Committee - only available in Spanish
2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish
The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish
The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish
Right to information - only available in Spanish
Link Right to Information - only available in Spanish
Attendance, Proxy and distance voting card - only available in Spanish
Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish
On-line Voting delegation - only available in Spanish
Regulations on electronic shareholder forum - only available in Spanish
Electronic Sharehoder Forum - only available in Spanish